Lexaria Bioscience Corp. (LEXX) stock
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
$4.44+0.26 (+6.22%)
Close on Nov 13, 2026Market cap $110.06MP/E –Yield –
Lexaria Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lexaria Bioscience's enterprise value was $110.98M on Nov 11, 2026, against $317.44M a year earlier. Over the last 5 years it ranged from $61.31M to $961.03M, with a median of $256.60M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $110.98M | -37.9% |
| 2025 | Dec 31, 2025 | $178.68M | -70.7% |
| 2024 | Dec 31, 2024 | $609.15M | +306.5% |
| 2023 | Dec 29, 2023 | $149.87M | -29.7% |
| 2022 | Dec 30, 2022 | $213.10M | -36.2% |
| 2021 | Dec 31, 2021 | $334.21M | -0.3% |
| 2020 | Dec 31, 2020 | $335.38M | -25.6% |
| 2019 | Dec 31, 2019 | $450.82M | -57.1% |
| 2018 | Dec 31, 2018 | $1.05B | -38.9% |
| 2017 | Dec 29, 2017 | $1.72B | +622.2% |
| 2016 | Dec 30, 2016 | $238.23M | – |
See a number that looks wrong?